Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · November 14, 2023

Ablative Carbon Dioxide Laser vs Intradermal Heparin Sodium for the Treatment of Patients With Xanthelasma

Photodermatology, Photoimmunology & Photomedicine


Additional Info

Photodermatology, Photoimmunology & Photomedicine
Clinical and dermoscopic assessment of ablative carbon dioxide laser versus intradermal heparin sodium in xanthelasma
Photodermatol Photoimmunol Photomed 2023 Sep 29;[EPub Ahead of Print], YME Neinaa, BSE Awara, OE Shalaby, NM Abd El-Naby

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading